Silvina Masciotra Selected Research

Immunoglobulin G (IgG)

1/2020	Could HIV-1 RNA Testing be an Option as the Second Step in the HIV Diagnostic Algorithm?
1/2017	Evaluation of dried blood spot protocols with the Bio-Rad GS HIV Combo Ag/Ab EIA and Geenius™ HIV 1/2 Supplemental Assay.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvina Masciotra Research Topics

Disease

13	Infections 01/2021 - 05/2002
6	HIV Infections (HIV Infection) 11/2020 - 12/2013
2	Viremia 01/2020 - 12/2014
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Hepatitis 01/2018
1	AIDS-Related Complex (ARC) 01/2017
1	Lentivirus Infections 09/2002

Drug/Important Bio-Agent (IBA)

5	AntigensIBA 01/2020 - 12/2013
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2017
2	Nucleic AcidsIBA 01/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
2	IntegrasesIBA 01/2018 - 09/2002
1	Broadly Neutralizing AntibodiesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	APTIBA 01/2020
1	GP 140IBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Opiate AlkaloidsIBA 11/2017
1	Explosive Agents (Explosives)IBA 11/2017
1	Immunoglobulin M (IgM)IBA 01/2017
1	HIV Reverse TranscriptaseIBA 12/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2014
1	HIV Core Protein p24IBA 12/2013
1	Antiviral Agents (Antivirals)IBA 01/2010
1	Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine FDA Link 01/2010
1	Chemokine ReceptorsIBA 05/2002
1	LigandsIBA 05/2002

Therapy/Procedure

2	Therapeutics 08/2018 - 01/2017
1	Art Therapy 01/2020